0001104659-20-134933.txt : 20201211 0001104659-20-134933.hdr.sgml : 20201211 20201211210036 ACCESSION NUMBER: 0001104659-20-134933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Astley-Sparke Philip CENTRAL INDEX KEY: 0001376491 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 201384905 MAIL ADDRESS: STREET 1: C/O BIOVEX GROUP, INC. STREET 2: 34 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 10801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2038101-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2020-12-09 0 0001737953 Replimune Group, Inc. REPL 0001376491 Astley-Sparke Philip C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK WOBURN MA 01801 1 1 0 0 Chief Executive Officer Common Stock 2020-12-09 4 S 0 600 45.79 D 1354697 D Common Stock 2020-12-09 4 S 0 6025 44.85 D 1348672 D Common Stock 2020-12-09 4 S 0 6459 43.88 D 1342213 D Common Stock 2020-12-09 4 S 0 11116 43.09 D 1331097 D Common Stock 2020-12-09 4 S 0 800 42.03 D 1330297 D Common Stock 2020-12-10 4 S 0 5086 43.72 D 1325211 D Common Stock 2020-12-10 4 S 0 16051 42.99 D 1309160 D Common Stock 2020-12-10 4 S 0 3863 42.39 D 1305297 D The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 6, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.47 to $45.56. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.40 to $44.41. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.40 to $43.42. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.40 to $42.48. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.29 to $41.78. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.45 to $43.46. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.45 to $42.46. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.45 to $42.26. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,305,297 shares of the Issuer's common stock. The reporting person also holds options to acquire 647,571 shares of the Issuer's common stock, 220,022 of which are exercisable as of the date hereof. /s/ Jean Franchi, attorney-in-fact 2020-12-11